Tumor necrosis factor in serum and in bronchoalveolar lavage of patients at risk for the adult respiratory distress syndrome
- 30 September 1992
- journal article
- Published by Elsevier in Journal of Critical Care
- Vol. 7 (3) , 183-188
- https://doi.org/10.1016/0883-9441(92)90015-y
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Plasma Tumor Necrosis Factor in Patients with Septic Shock: Mortality Rate, Incidence of Adult Respiratory Distress Syndrome, and Effects of Methylprednisolone AdministrationAmerican Review of Respiratory Disease, 1989
- The presence of cachectin/tumor necrosis factor in human disease statesThe American Journal of Medicine, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Tumor Necrosis Factor Causes Increased Pulmonary Permeability and Edema: Comparison to Septic Acute Lung InjuryAmerican Review of Respiratory Disease, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERThe Lancet, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONSThe Lancet, 1986
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985